annual cash & cash equivalents:
$47.25M-$26.84M(-36.23%)Summary
- As of today (July 6, 2025), HROW annual cash & cash equivalents is $47.25 million, with the most recent change of -$26.84 million (-36.23%) on December 31, 2024.
- During the last 3 years, HROW annual cash & cash equivalents has risen by +$5.08 million (+12.05%).
- HROW annual cash & cash equivalents is now -50.92% below its all-time high of $96.27 million, reached on December 31, 2022.
Performance
HROW Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$66.73M+$19.48M(+41.23%)Summary
- As of today (July 6, 2025), HROW quarterly cash & cash equivalents is $66.73 million, with the most recent change of +$19.48 million (+41.23%) on March 31, 2025.
- Over the past year, HROW quarterly cash & cash equivalents has dropped by -$1.81 million (-2.64%).
- HROW quarterly cash & cash equivalents is now -30.69% below its all-time high of $96.27 million, reached on December 31, 2022.
Performance
HROW quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HROW Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.2% | -2.6% |
3 y3 years | +12.1% | +59.1% |
5 y5 years | +894.9% | +1600.5% |
HROW Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -50.9% | +12.1% | -30.7% | +246.7% |
5 y | 5-year | -50.9% | +1052.1% | -30.7% | +1610.0% |
alltime | all time | -50.9% | >+9999.0% | -30.7% | >+9999.0% |
HROW Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $66.73M(+41.2%) |
Dec 2024 | $47.25M(-36.2%) | $47.25M(-34.9%) |
Sep 2024 | - | $72.60M(+2.3%) |
Jun 2024 | - | $70.97M(+3.5%) |
Mar 2024 | - | $68.54M(-7.5%) |
Dec 2023 | $74.08M(-23.0%) | $74.08M(+12.9%) |
Sep 2023 | - | $65.61M(+188.3%) |
Jun 2023 | - | $22.75M(+18.2%) |
Mar 2023 | - | $19.25M(-80.0%) |
Dec 2022 | $96.27M(+128.3%) | $96.27M(+114.1%) |
Sep 2022 | - | $44.96M(-3.2%) |
Jun 2022 | - | $46.44M(+10.7%) |
Mar 2022 | - | $41.95M(-0.5%) |
Dec 2021 | $42.17M(+928.2%) | $42.17M(-26.9%) |
Sep 2021 | - | $57.66M(-20.6%) |
Jun 2021 | - | $72.65M(+1052.5%) |
Mar 2021 | - | $6.30M(+53.7%) |
Dec 2020 | $4.10M(-13.6%) | $4.10M(-25.8%) |
Sep 2020 | - | $5.53M(+41.6%) |
Jun 2020 | - | $3.90M(-0.6%) |
Mar 2020 | - | $3.92M(-17.4%) |
Dec 2019 | $4.75M(-28.5%) | $4.75M(+38.4%) |
Sep 2019 | - | $3.43M(-14.1%) |
Jun 2019 | - | $3.99M(-6.4%) |
Mar 2019 | - | $4.26M(-35.7%) |
Dec 2018 | $6.64M(+65.2%) | $6.64M(+5.1%) |
Sep 2018 | - | $6.32M(+51.4%) |
Jun 2018 | - | $4.17M(+54.9%) |
Mar 2018 | - | $2.69M(-33.0%) |
Dec 2017 | $4.02M(-54.6%) | $4.02M(+3.9%) |
Sep 2017 | - | $3.87M(-7.2%) |
Jun 2017 | - | $4.17M(-43.7%) |
Mar 2017 | - | $7.40M(-16.5%) |
Dec 2016 | $8.85M(+229.7%) | $8.85M(+274.8%) |
Sep 2016 | - | $2.36M(-56.6%) |
Jun 2016 | - | $5.44M(-54.0%) |
Mar 2016 | - | $11.82M(+340.3%) |
Dec 2015 | $2.69M | $2.69M(-59.0%) |
Sep 2015 | - | $6.56M(-34.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $10.05M(+246.8%) |
Mar 2015 | - | $2.90M(-64.7%) |
Dec 2014 | $8.21M(-47.3%) | $8.21M(-20.8%) |
Sep 2014 | - | $10.36M(-14.4%) |
Jun 2014 | - | $12.10M(-14.8%) |
Mar 2014 | - | $14.20M(-8.8%) |
Dec 2013 | $15.58M(+55.2%) | $15.58M(-7.4%) |
Sep 2013 | - | $16.83M(-6.4%) |
Jun 2013 | - | $17.97M(-5.3%) |
Mar 2013 | - | $18.98M(+89.1%) |
Dec 2012 | $10.04M(+6764.3%) | $10.04M(-8.7%) |
Sep 2012 | - | $10.99M(+42.4%) |
Jun 2012 | - | $7.72M(+5160.6%) |
Mar 2012 | - | $146.70K(+0.3%) |
Dec 2011 | $146.20K(-49.8%) | $146.20K(+6545.5%) |
Sep 2011 | - | $2200.00(-60.7%) |
Jun 2011 | - | $5600.00(-92.1%) |
Mar 2011 | - | $70.90K(-75.7%) |
Dec 2010 | $291.50K(-81.7%) | $291.50K(-37.6%) |
Sep 2010 | - | $467.30K(-55.2%) |
Jun 2010 | - | $1.04M(+9.5%) |
Mar 2010 | - | $951.90K(-40.1%) |
Dec 2009 | $1.59M(-68.9%) | $1.59M(-20.5%) |
Sep 2009 | - | $2.00M(-31.1%) |
Jun 2009 | - | $2.90M(-30.8%) |
Mar 2009 | - | $4.19M(-18.0%) |
Dec 2008 | $5.11M(+37.9%) | $5.11M(-11.5%) |
Sep 2008 | - | $5.78M(-13.9%) |
Jun 2008 | - | $6.71M(+96.9%) |
Mar 2008 | - | $3.41M(-8.0%) |
Dec 2007 | $3.71M(>+9900.0%) | $3.71M(-13.8%) |
Sep 2007 | - | $4.30M(>+9900.0%) |
Aug 2007 | - | $14.30K(-15.9%) |
May 2007 | - | $17.00K(-38.0%) |
May 2007 | $17.00K(-57.4%) | - |
Feb 2007 | - | $27.40K(0.0%) |
Nov 2006 | - | $27.40K(-3.9%) |
Aug 2006 | - | $28.50K |
May 2006 | $39.90K | - |
FAQ
- What is Harrow Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Harrow Health?
- What is Harrow Health annual cash & cash equivalents year-on-year change?
- What is Harrow Health quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Harrow Health?
- What is Harrow Health quarterly cash & cash equivalents year-on-year change?
What is Harrow Health annual cash & cash equivalents?
The current annual cash & cash equivalents of HROW is $47.25M
What is the all time high annual cash & cash equivalents for Harrow Health?
Harrow Health all-time high annual cash & cash equivalents is $96.27M
What is Harrow Health annual cash & cash equivalents year-on-year change?
Over the past year, HROW annual cash & cash equivalents has changed by -$26.84M (-36.23%)
What is Harrow Health quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of HROW is $66.73M
What is the all time high quarterly cash & cash equivalents for Harrow Health?
Harrow Health all-time high quarterly cash & cash equivalents is $96.27M
What is Harrow Health quarterly cash & cash equivalents year-on-year change?
Over the past year, HROW quarterly cash & cash equivalents has changed by -$1.81M (-2.64%)